Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled abatacept study in active Crohn's disease
2006-003371-13Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of abatacept in Crohn's disease (3 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Clinical response on Days IP-57 and IP-85. Started Dec 2006; status: completed.
02
Drugs
abatacept
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2006-003371-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003371-13.